Based on our Special European Physician & Payer Forum report entitled Metastatic Colorectal Cancer in Europe: Changing Dynamics in Light of Increasing Segmentation and New Therapeutic Options, Decision Resources is offering an exclusive webinar entitled Erbitux is Poised to Threaten Avastin’s Dominance in Early Lines of Treatment for Colorectal Cancer in Europe. Because this webinar features major report findings, it is ONLY available to purchasers of this report.
This webinar was held on December 16, 2009. Contact us to learn how you can purchase this report and access a recorded playback of this event.
Click here to view the invite.